Vaccinations
744 results
1 - 100
9-valent HPV vaccine offers only small advantage over quadrivalent vaccine- Increased vaccine exposure not linked to increased risk of non-vaccine-targeted infections in children
- Influenza vaccination during pregnancy is effective
- Malaria vaccine effective in children
- Same-day COVID-19 and seasonal influenza vaccines are as effective as each vaccine given separately
- Persistence improves HPV vaccine uptake
- Enhanced influenza vaccines prevent more hospitalizations than standard-dose influenza vaccines in older adults
- Autism not linked to thimerosol in vaccines
- Tetravalent dengue vaccine effective in children
- Pneumococcal conjugate vaccine prevents meningitis
- Early vaccinations not associated with celiac disease
- Pneumonia vaccine effective in nursing homes
- Flu vaccine does not increase fever frequency when added to the 12- to 16-month vaccine line-up
- Hep A vaccine similar to immune globulin for postexposure prophylaxis
- Pneumococcal polysaccharide vaccine of questionable benefit for adults
- Once again, autism not linked to MMR vaccine
- Vaccines for rotavirus increase risk of intussusception slightly
- Recombinant herpes zoster vaccine highly effective
- Febrile seizure outcomes similar with or without association to vaccination
- Menveo meningitis vaccine may be associated with Bell's palsy
- Influenza (H1N1) vaccination during pregnancy not associated with autism
- Egg-allergic children can receive influenza vaccine
- HPV vaccine not effective in treating women with preexisting HPV infection
- Adjuvant increases efficacy of influenza vaccine in infants and children
- Meningococcal vaccine effectiveness wanes over 8 years
- Flu vaccine not associated with flares in patients with rheumatoid disorders
- MMRV vaccine slightly increases febrile seizure risk
- MMR vaccine appears to be safe for children with juvenile arthritis
- COVID-19 vaccine is not associated with adverse birth outcomes
- Inadvertent HPV vaccine in pregnancy is not associated with adverse outcomes
- HPV vaccine prevents external genital lesions in young men
- Sudden hearing loss not linked to COVID-19 infection or vaccination
- HPV-16 vaccine may be effective for vulvar intraepithelial neoplasia
- Live attenuated influenza vaccine not effective in recent US flu seasons
- Likelihood of long COVID varies by variant, sex, and vaccination status
- Quadrivalent flu vaccine is safe and effective, but may not be better than trivalent
- HPV vaccine not associated with chronic fatigue or other autonomic dysfunction syndromes
- Similar likelihood of adverse effects with mRNA and inactivated virus vaccines for COVID-19
- HPV vaccination decreased diagnoses of CIN grade 3 or worse by 89%
- Vaccines are only slightly less effective against the delta variant
- Live attenuated nasal flu vaccine safe, effective for ages 1 to 5
- A third dose of mumps vaccine during an outbreak reduces the risk of infection
- Influenza vaccine during pregnancy not associated with adverse childhood health outcomes
- HPV testing better than cytology for women vaccinated against HPV
- Low risk of second allergic reaction to SARS-CoV-2 vaccines
- mRNA COVID-19 vaccines are associated with a small increase in myocarditis
- New zoster vaccine prevents more cases, but causes more sore arms
- Quadrivalent HPV vaccine prevents CIN 2/3, anogenital warts (FUTURE II)
- BNT162b2 COVID-19 vaccination during pregnancy is not associated with adverse neonatal outcomes
- Bell palsy is associated with COVID-19 infection to a greater degree than with vaccination
- Why families who resist vaccines should not be banned from medical practices
- Pfizer-BioNTech vaccine booster reduces mortality due to COVID-19 by 90%
- Flu vaccine reduces risk of adverse CV events in high-risk patients
- H1N1 influenza vaccination during pregnancy not associated with problems in exposed offspring
- Nirmatrelvir-ritonavir (Paxlovid) continues to provide a benefit, especially in the elderly and less vaccinated
- Specific antibodies are present in breast milk after maternal mRNA vaccination
- MMR vaccine not associated with increased autism risk in children with older siblings with autism
- Vaccine safe and effective for prevention of EV71 disease (NNT = 50 over 1 year)
- Patient reminders combined with clinician audit and feedback increases human papillomavirus vaccine uptake
- Pfizer mRNA vaccine highly effective in a real-world population–based study in Israel
- Zoster vaccine not associated with increased risk of HZ infection in immune-mediated disease patients
- Quadrivalent recombinant influenza vaccine seems safe and effective for adults older than 50 years
- Very low incidence of acute myocarditis after mRNA COVID-19 vaccination in young adults
- Fourth dose of Pfizer-BioNTech COVID-19 vaccine is effective in persons 60 and older
- High-dose recombinant flu vaccine: NNT = 3000 to prevent one more infection, no impact on hospitalization
- Hybrid and natural immunity are robust but, like vaccine immunity, wane over time
- Oral antivirals reduce hospitalization and death in immunocompromised vaccinated patients with COVID-19
- Waning immunity to symptomatic infection with Delta variant, but not to hospitalization or death, 20 weeks after vaccination
- COVID-19 mRNA vaccine given in third-trimester pregnancy is not associated with adverse maternal outcomes
- Molnupiravir shortens duration but does not decrease hospitalizations/deaths in vaccinated adults with COVID-19 (PANORAMIC)
- The risk of PASC (long COVID) is decreasing but remains substantial at 3.5% for vaccinated persons in the omicron era
- Pfizer/BioNTech mRNA vaccine is highly effective and safe in adolescents aged 12 to 15 years
- RSV vaccine is safe and effective in adults 60 years and older, but the absolute risk reduction is small
- Flu vaccine for surgical inpatients not associated with higher health care use in the immediate postdischarge period
- Influenza vaccine shortly after myocardial infarction reduces 1-year mortality (NNT = 50)
- High-dose vaccine reduces clinical flu in elderly compared with standard dose (NNT = 220)
- Vaccine prevents active tuberculosis in adults with latent tuberculosis (NNT = 333 over 3 years)
- Human papillomavirus vaccine, especially before age 17, is associated with a large reduction in invasive cervical cancer
- High-dose influenza vaccine no more effective than the standard dose for adults with high-risk cardiovascular disease
- COVID-19 research briefs: Persistent fatigue, dyspnea common following hospitalization; promising vaccine developed in China
- Bivalent respiratory syncytial virus (RSV) vaccine given to mothers reduces total and severe RSV infections in infants
- Rate of new-onset seizures is less than 0.01% among SARS-CoV-2 vaccine recipients and placebo recipients
- COVID-19 vaccine moderately effective (48%) at preventing symptomatic infection in children 5 to 11 years old
- Longer interval between doses of the Oxford/AstraZeneca vaccine may provide greater immunity against COVID-19
- Booster with Pfizer mRNA vaccine significantly reduces likelihood of infection and severe illness due to COVID-19 in adults 60+
- Nirmatrelvir-ritonavir (Paxlovid) doesn't significantly reduce symptoms or hospitalization in vaccinated high-risk patients and unvaccinated patients
- COVID-19 research briefs: Promising preliminary data on COVID-19 vaccines from the United States and United Kingdom
- Third Pfizer vaccine dose significantly increases protection against both mild and severe COVID-19 in patients 60 years+
- Single dose of a typhoid conjugate vaccine (Vi-TT) is 78% effective for 4 years in children who live in endemic areas
- mRNA vaccine in children aged 5 to 11 years is associated with fewer symptomatic COVID-19 infections and less multisystem inflammatory syndrome
- Three-dose vaccine or 2 doses + previous infection protect against severe disease from BA.1 or BA.2 COVID-19 variants
- Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age